| Outer membrane vesicles (OMVs) produced by gram-negative bacteria: structure, functions, biogenesis, and vaccine application N Furuyama, MP Sircili BioMed Research International 2021, 2021 | 71 | 2021 |
| An improved whole cell pertussis vaccine with reduced content of endotoxin W Dias, AAJ van der Ark, MA Sakauchi, FS Kubrusly, AFRO Prestes, ... Human vaccines & immunotherapeutics 9 (2), 339-348, 2013 | 57 | 2013 |
| New approaches in pertussis vaccines for developing countries WO Dias, LCC Leite, D Horton, MA Sakauchi, FS Kubrusly, N Furuyama, ... Communicating Current Research and Educational Topics and Trends in Applied …, 2007 | 5 | 2007 |
| Vitamin A as adjuvant to the mouse immune response to pertussis, tetanus and diphtheria vaccines WO Dias, DSPQ Horton, VCB Cainelli Gebara, N Furuyama, L Risoléo, ... Biotechnology letters 24, 1515-1518, 2002 | 5 | 2002 |
| Cultivo de ESCHERICHIA COLI e extração de OMV para combate de infecções hospitalares JCA Silva, N Furuyama | | 2018 |
| Processo de obtenção de soro equino anti-loxoscélico C Bioindustrial, I Raw, WO Dias, DSPQ Horton, N Furuyama, W Quintilio, ... Instituto Nacional de Propriedade Industrial, 2007 | | 2007 |
| Produção de toxina Pertussis por fermentação submersa em biorreatores N Furuyama, H Hiss | | 2006 |
| Avaliação de procedimento de destoxificação de toxina pertussis, em vacina pertussis acelular desenvolvida no Instituto Butantan N Furuyama, I Raw | | 2001 |
| Evaluation of the adjuvant activity induced by Bordetella pertussis cell wall soluble fractions VCB Cainelli Gebara, WO Dias, D Horton, N Furuyama, RC Vassão, ... Summary, 1998 | | 1998 |
